ClinicalTrials.Veeva

Menu

Pressure Wire Guidance for Infrapopliteal Artery Interventions

Yonsei University logo

Yonsei University

Status

Enrolling

Conditions

Chronic Limb-Threatening Ischemia

Treatments

Procedure: Pressure wire-guided angioplasty
Procedure: Angiography-guided angioplasty

Study type

Interventional

Funder types

Other

Identifiers

NCT06879561
1-2024-0068

Details and patient eligibility

About

"• A prospective, single-center randomized controlled comparison trial.

  • A total of 100 patients with symptoms of chronic limb-threatening ischemia (Rutherford category 5) undergoing endovascular treatment for anterior tibial artery or posterior tibial artery lesions will be included if they meet the inclusion criteria and do not meet any exclusion criteria.
  • Patients will be randomized in a 1:1 open-label manner either to the pressure wire-guided group or the angiography-guided group.
  • Patients will be treated with balloon angioplasty for anetrior tibial artery or posterior tibial artery lesions.
  • In the angiography-guided group, balloon angioplasty will be performed to achieve an optimal procedural result, as determined by angiography. Optimal results are defined as antegrade blood flow without residual stenosis >50% or flow-limiting dissection.
  • In the Pressure Wire-guided gorup, balloon angioplasty will be performed to obtain optimal procedural result based on both angiography and a pressure gradient over the target lesion. Optimal pressure gradient is less than 10 mmHg by measurement using a Pressure Wire.
  • The primary efficacy endpoint is defined by attaiment of skin perfusion pressure ≥50 mmHg within 1-3 days after the index procedure.
  • Patients will be followed at 1, 3, and 6 months after the procdure to assess wound healing status, and clinical events."

Full description

  1. Prospective, singlecenter, open label, randomized controlled study
  2. Eligible patients with chronic limb-threatening ischemia (Rutherford category 5) undergoing endovascular treatment for anterior tibial artery or posterior tibial artery lesions will be randomized to pressure wire-guided or angiography-guided groups.
  3. All patients will undergo balloon angioplasty for anterior or posterior tibial artery lesions, with the angiography-guided group aiming for optimal procedural results based on angiography, and the pressure wire-guided group aiming for optimal results based on both angiography and pressure gradient measurements.
  4. The primary efficacy endpoint is attainment of skin perfusion pressure ≥50 mmHg within 1-3 days after the procedure.
  5. Clinical follow-up will occur at 1, 3, and 6 months to assess wound healing and clinical events.

Enrollment

100 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with chronic limb threatening ischemia (Rutherford 5)
  • Anterior tibial artery or posterior tibial artery lesions ≥ 10 cm Age ≥19 years

Exclusion criteria

  • Acute limb ischemia

  • Contraindication to antiplatelet or anticoagulation agents:

    1. Thrombocytopenia (platelet <100,000/uL)
    2. Previous cerebral hemorrhage, GI bleeding, other reasons for increased bleeding risk within 6 months
  • Pregnant women or women with potential childbearing

  • Life expectancy < 1 year

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Angiography-guided angioplasty
Active Comparator group
Description:
In this group, balloon angioplasty will be performed on the target infrapopliteal artery lesion to achieve an optimal procedural result, as determined by angiography. Optimal results are defined as antegrade blood flow without residual stenosis \>50% or any flow-limiting dissection.
Treatment:
Procedure: Angiography-guided angioplasty
Pressure wire-guided angioplasty
Experimental group
Description:
In this gorup, balloon angioplasty will be performed on the target infrapopliteal artery lesions to achieve an optimal procedural result, as determined by the pressure gradient across the target lesion. An optimal procedural result is defined as pressure gradient less than 10 mmHg, measured using a Pressure Wire.
Treatment:
Procedure: Pressure wire-guided angioplasty

Trial contacts and locations

1

Loading...

Central trial contact

Young-Guk Ko, MD. Division of Cardiology

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems